Role of Adipose Tissue Insulin Resistance in the Natural History of Type 2 Diabetes: Results From the San Antonio Metabolism Study
The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
In the transition from normal glucose tolerance (NGT) to type 2 diabetes mellitus (T2DM), the role of β-cell dysfunction and peripheral insulin resistance (IR) is well established. However, the impact of dysfunctional adipose tissue has not been fully elucidated. The aim of this study was to evaluate the role of resistance to the antilipolytic effect of insulin (adipose tissue IR [Adipo-IR]) in a large group of subjects with NGT, impaired glucose tolerance (IGT), and T2DM. Three hundred two subjects with varying glucose tolerance received an oral glucose tolerance test (OGTT) and euglycemic insulin clamp. We evaluated Adipo-IR (fasting and mean OGTT plasma free fatty acid [FFA] × insulin concentrations), peripheral IR (1/[Matsuda index] and (M/I)−1 value), and β-cell function (calculated as the ratio of the increment in plasma insulin to glucose [OGTT/IR (ΔI/ΔG ÷ IR)]). Fasting Adipo-IR was increased twofold in obese subjects with NGT and IGT versus lean subjects with NGT (8.0 ± 1.1 and 9.2 ± 0.7 vs. 4.1 ± 0.3, respectively) and threefold in subjects with T2DM (11.9 ± 0.6; P < 0.001). Progressive decline in ΔI/ΔG ÷ IR was associated with a progressive impairment in FFA suppression during OGTT, whereas the rise in mean plasma glucose concentration only became manifest when subjects became overtly diabetic. The progressive decline in β-cell function that begins in individuals with NGT is associated with a progressive increase in FFA and fasting Adipo-IR.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, in the presence of Adipo-IR, FFA release is not suppressed despite high insulin concentrations.45”
From Lipid metabolism in MASLD and MASH: From mechanism to the clinic (2024) · cites this paper as [45]
Citations
Cites
Matsuda, M., & DeFronzo, R. A. (1999) · Diabetes Care · doi:10.2337/diacare.22.9.1462 · Cited by 5,621 · cited 1×
“Data Analysis Insulin sensitivity was assessed by Matsuda index (32) from the plasma glucose and insulin concentrations measured during the OGTT.”
MethodSelf-citationAdipose Tissue as an Endocrine Organ
Kershaw, E. E., & Flier, J. S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0395 · Cited by 5,522
DeFronzo, R. A. (2009) · Diabetes · doi:10.2337/db09-9028 · Cited by 3,016
Self-citationPathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future
Kahn, S. E., Cooper, M. E., & Del Prato, S. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62154-6 · Cited by 1,743 · cited 1×
“Thus, with progression from lean NGT to obese NGT to IGT, the insulin secretion/insulin resistance (disposition) index declined and was closely related to the deterioration in OGTT, consistent with previous studies from our group and others (31,34,39,40).”
ResultMechanism of free fatty acid-induced insulin resistance in humans.
Roden, M., Price, T. B., Perseghin, G., Petersen, K. F., Rothman, D. L., Cline, G. W., & Shulman, G. I. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118742 · Cited by 1,539 · cited 1×
“, the impaired suppression of lipolysis in the presence of high insulin levels, has been associated with glucose intolerance, and elevated plasma FFA have been shown to impair muscle insulin signaling, promote hepatic gluconeogenesis, and impair glucose-stimulated insulin response (7-13).”
BackgroundScherer, P. E. (2006) · Diabetes · doi:10.2337/db06-0263 · Cited by 1,066
Effect of fatty acids on glucose production and utilization in man.
Ferrannini, E., Barrett, E. J., Bevilacqua, S., & DeFronzo, R. A. (1983) · Journal of Clinical Investigation · doi:10.1172/jci111133 · Cited by 1,050 · cited 1×
“, the impaired suppression of lipolysis in the presence of high insulin levels, has been associated with glucose intolerance, and elevated plasma FFA have been shown to impair muscle insulin signaling, promote hepatic gluconeogenesis, and impair glucose-stimulated insulin response (7-13).”
BackgroundSelf-citationFatty acids, obesity, and insulin resistance: Time for a reevaluation
Karpe, F., Dickmann, J. R., & Frayn, K. N. (2011) · Diabetes · doi:10.2337/db11-0425 · Cited by 896 · cited 1×
“In contrast to the OGTT, studies with the stepped hyperinsulinemic clamp consistently have demonstrated impaired suppression of plasma FFA and glycerol concentrations and (14)C-palmitate turnover (18,22,24) (i.”
ResultBoden, G. (2008) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2008.06.007 · Cited by 853 · cited 1×
“Insulin acts on adipose tissue 1) by stimulating glucose uptake and triglyceride synthesis and 2) by suppressing triglyceride hydrolysis and release of FFA and glycerol into the circulation (6,7).”
BackgroundGroop, L. C., Bonadonna, R. C., DelPrato, S., Ratheiser, K., Zyck, K., Ferrannini, E., & DeFronzo, R. A. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114142 · Cited by 812 · cited 4×
“In contrast to the OGTT, studies with the stepped hyperinsulinemic clamp consistently have demonstrated impaired suppression of plasma FFA and glycerol concentrations and (14)C-palmitate turnover (18,22,24) (i.”
BackgroundMethodResultInfluentialSelf-citation
Cited by
Items 201–300 of 346
Luchsinger, J. A., Kazemi, E. J., Sanchez, D. L., Larkin, M., Valencia, W. M., Desouza, C. V., Carlson, A. L., Pop‐Busui, R., Seaquist, E. R., Florez, H. J., et al. (2023) · Obesity · doi:10.1002/oby.23785 · Cited by 10
Galarza, E. J., Medina-Urrutia, A. X., Reyes-Barrera, J., Torres‐Tamayo, M., Montaño, L. F., Páez, A., Massó, F., & Juárez-Rojas, J. G. (2023) · Lipids in Health and Disease · doi:10.1186/s12944-023-01847-7 · Cited by 9
“[19] The above agrees with the results of the present study, as we observed a gradual increase in the ATIR index in subjects with prediabetes and T2D.”
BackgroundResultExercise in the Prevention and Treatment of Type 2 Diabetes
Kirwan, J. P., Heintz, E. C., Rebello, C. J., & Axelrod, C. L. (2023) · Comprehensive physiology · doi:10.1002/j.2040-4603.2023.tb00259.x · Cited by 18
“A progressive decline in β -cell function is associated with incremental increases in free fatty acids (FFAs) and fasting adipose tissue insulin resistance (96).”
Melo, D. D. S., SANTOS, C. D. S., Pereira, L. C., Mendes, B. F., Jesus, L. S., Pelaez, J. M. N., Aguilar, E. C., Nascimento, D. R., Martins, A. S., Magalhães, F. D. C., et al. (2019) · Nutrition · doi:10.1016/j.nut.2019.03.022 · Cited by 10
Zhang, S., Wang, Y., Wang, X., Leng, M., Liu, R., Li, Z., Li, J., Xiao, J., Hou, D., Gao, X., et al. (2025) · BMC Medicine · doi:10.1186/s12916-025-04072-4 · Cited by 11
“The calculation formulas for HOMA-IR, HOMA-AD and Adipo-IR were as follows: HOMA-IR = FPG (mmol/L) × FINS (IU/L) /22.5 [12], HOMA-AD = (FPG (mmol/L) × FINS (IU/L))/(22.5 × adiponectin (μg/mL)) [13], Adipo-IR = FFA (mmol/L) × FINS (IU/L) [14].”
InfluentialMajid, H., Dahalia, M., Hussain, S., Saini, S., & Nidhi, N. (2025) · Diabetology International · doi:10.1007/s13340-025-00830-0 · Cited by 7
“Fatty acyl-CoA, a key metabolite, regulates acetyl-CoA carboxylase (ACC), the enzyme catalyzing the first step in FA synthesis [88, 89].”
Marcoux, C., Morin, R., Mauger, J., & Imbeault, P. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.937127 · Cited by 9
“…was measured by enzyme-linked immunosorbent assay kits (EMD Millipore, MA, United States), from which the Adipo-IR was calculated, as previously reported, by multiplying the NEFA concentration (mmol/L) by the insulin concentration (pmol/L) (Gastaldelli et al., 2017; Søndergaard et al., 2017).”
MethodIncreased obesogenic action of palmitic acid during early stage of adipogenesis
Stanek, E., Czamara, K., & Kaczor, A. A. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2024.159525 · Cited by 8
Brachs, S., Soll, D., Beer, F., Huckauf, N., Konkar, A. A., Spranger, J., Rütten, H., & Mai, K. (2025) · European Journal of Endocrinology · doi:10.1093/ejendo/lvae151 · Cited by 7
Niemiro, G. M., Skinner, S. K., Walk, A. M., Edwards, C., Lisio, M. D., Holscher, H. D., Burd, N. A., & Khan, N. A. (2018) · Obesity · doi:10.1002/oby.22276 · Cited by 8
Behn, C. D., Jin, E. S., Bubar, K. M., Malloy, C. R., Parks, E. J., & Cree‐Green, M. (2019) · Journal of Investigative Medicine · doi:10.1136/jim-2019-001109 · Cited by 8
Juárez-Rojas, J. G., Torre-Villalvazo, I., Medina-Urrutia, A. X., Reyes-Barrera, J., Sainz-Escárrega, V. H., Posadas‐Romero, C., Macías-Cruz, A., & Galarza, E. J. (2019) · International Journal of Obesity · doi:10.1038/s41366-019-0493-y · Cited by 7
Lu, X., Wang, Q., Liang, H., Xu, L., Sha, L., Wu, Y., Ma, L., Yang, P., & Lei, H. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s314935 · Cited by 7
Fructose and follistatin potentiate acute MASLD during complete hepatic insulin resistance
Tao, R., Stöhr, O., Tok, O., Andrés-Hernando, A., Qiu, W., He, B., Wang, C., Grøntved, L., Burant, C., Hui, S. T., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-66296-5 · Cited by 7
“Adipose IR is present early in the natural history of T2D, resulting in uncontrolled lipolysis that increases fl ux of FFA to the liver 47 .”
Roberts‐Thomson, K. M., Hu, D., Russell, R., Greenaway, T. M., Betik, A. C., Parker, L., Kaur, G., Richards, S. M., Premilovac, D., Wadley, G. D., et al. (2022) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00109.2022 · Cited by 6
Ezeh, U. I., Chen, Y. I., Pall, M., Buyalos, R. P., Chan, J. L., Pisarska, M. D., & Azziz, R. (2024) · Fertility and Sterility · doi:10.1016/j.fertnstert.2024.01.030 · Cited by 6
Channar, P. A., Aziz, M., Ejaz, S. A., Saeed, A., Ujan, R., Channar, S. A., Alotaibi, S. S., Flörke, Ü., Bolte, M., & Hökelek, T. (2024) · Results in Chemistry · doi:10.1016/j.rechem.2024.101537 · Cited by 6
SMIM1 absence is associated with reduced energy expenditure and excess weight
Stefanucci, L., Moslemi, C., Tomé, A. R., Virtue, S., Bidault, G., Gleadall, N., Watson, L. P. E., Kwa, J. E., Burden, F., Farrow, S., et al. (2024) · Med · doi:10.1016/j.medj.2024.05.015 · Cited by 9
Zhang, Y.-J., Du, M., Li, Z., Wang, X., Leng, M., Huang, Y., Li, L., Zhang, S., & Li, C. (2024) · International Journal of Endocrinology · doi:10.1155/2024/1297584 · Cited by 6
“The formula for calculating adipose tissue insulin resistance (ADIPO-IR) [17] was free fatty acid (FFA) (mmol/L) * FINS (µU/mL).”
BackgroundPrecision-cut liver slices as an ex vivo model to assess impaired hepatic glucose production
Kiyuna, L. A., Krishnamurthy, K. A., Homan, E., Langelaar‐Makkinje, M., Gerding, A., Bos, T., Oosterhuis, D., Overduin, R. J., Schreuder, A. B., de Meijer, V. E., et al. (2024) · Communications Biology · doi:10.1038/s42003-024-07070-z · Cited by 6
Vallazhath, A., Thimmappa, P. Y., Joshi, H. B., Hebbar, K. R., Nayak, A. V., Umakanth, S., Saoji, A. A., Manjunath, N. K., Hadapad, B. S., & Joshi, M. B. (2025) · Nutrition and Diabetes · doi:10.1038/s41387-025-00371-0 · Cited by 6
“High FFA plasma levels are associated with glucose intolerance, disrupted muscle insulin signalling, increased hepatic gluconeogenesis, and reduced insulin response to glucose [39].”
Lee, S. W., Dien, C. V., & Won, S. J. (2020) · HCA Healthcare Journal of Medicine · doi:10.36518/2689-0216.1102 · Cited by 6
Święcicka-Klama, A., Połtyn–Zaradna, K., Wołyniec, M., Szuba, A., & Zatońska, K. (2021) · Advances in experimental medicine and biology · doi:10.1007/5584_2021_681 · Cited by 6
Zaharia, O., Schön, M., Löffler, L., Straßburger, K., Möser, C., Yurchenko, I., Bódis, K. B., Antoniou, S., Karusheva, Y., Szendroedi, J., et al. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac480 · Cited by 9
Zarkesh, M., Saba, R., Aghazadeh, H., Teymoori, F., Akbarzadeh, M., Asghari, G., Montazeri, M., Ghasemi, A., Yuzbashian, E., Zadeh–Vakili, A., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-05233-4 · Cited by 5
Lipidomic profiling unveils sex differences in diabetes risk: Implications for precision medicine
Pina, A. F., Meneses, M. J., Carli, F., Patrício, B., Ribeiro, R. T., Patarrão, R. S., Gardete-Correia, L., Duarte, R., Boavida, J. M., Raposo, J. F., et al. (2025) · European Journal of Clinical Investigation · doi:10.1111/eci.70137 · Cited by 8
Self-citationPepa, G. D., Carli, F., Sabatini, S., Pezzica, S., Russo, M., Vitale, M., Masulli, M., Riccardi, G., Rivellese, A. A., Vaccaro, O., et al. (2024) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3798 · Cited by 6
“4 Taken together, our data suggest that not glucose control but rather IR has an impact on the lipidomic profile and highlight the relevance of adipose tissue dysfunction as a major contributor to the lipidomic signature in T2D and increased CVD risk.”
BackgroundInfluentialSelf-citationKim, H. J., Kim, Y. J., & Seong, J. K. (2025) · The Journal of Physiology · doi:10.1113/jp285975 · Cited by 5
“…et al., 2006; Guilherme et al., 2008), and increased insulin resistance increases the absorption of fatty acids and inhibits lipolysis (Gastaldelli et al., 2017), stimulating the accumulation of ectopic fat in tissues such as the liver, muscle, pancreas and heart (Gyllenhammer et al.,…”
Fat absorption and metabolism after Roux-en-Y gastric bypass surgery
HINDSØ, M. G., Lundsgaard, A., Marinkovic, B., Jensen, M. H., Hedbäck, N., Svane, M. S., Dirksen, C., Jørgensen, N. B., London, A., Jeppesen, P. B., et al. (2025) · Metabolism · doi:10.1016/j.metabol.2025.156189 · Cited by 7
Leptin and Obesity: Understanding the Impact on Dyslipidemia
Rangareddy, H., Venkatapathappa, P., Mandalaneni, K., Srinivasaiah, A., & Bourne-Yearwood, K. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.112499 · Cited by 7
Sato, M., Tamura, Y., Kaga, H., Yamasaki, N., Kadowaki, S., Sugimoto, D., Nakagata, T., Someya, Y., Nishida, Y., Kawamori, R., et al. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1390778 · Cited by 5
“This adverse metabolic feature is observed in various obesity-associated diseases, including non-alcoholic fatty liver disease, metabolic syndrome, impaired glucose tolerance (IGT), and type 2 diabetes (5 – 8).”
BackgroundDing, W., Fang, C., Wang, L., & Fang, C. (2024) · Medicine · doi:10.1097/md.0000000000040534 · Cited by 5
“[32] Both hyperglycemia and β -cell injury are associated with cardiomyocyte metabolism and cardiac function.”
Li, F., Xu, S., & Lian, Q. (2022) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2022-0354 · Cited by 5
Queathem, E. D., Fitzgerald, M., Welly, R. J., Rowles, C. C., Schaller, K., Bukhary, S., Baines, C. P., Rector, R. S., Padilla, J., Manrique‐Acevedo, C., et al. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.920675 · Cited by 6
“Given the established link between adipose tissue dysfunction and multiple metabolic diseases (Klöting et al., 2010; Haas et al., 2012; Lomonaco et al., 2012; Klöting and Blüher, 2014; Gastaldelli et al., 2017; Norheim et al., 2019; Sergi et al., 2019), therapeutics specifically targeting adipocytes are urgently neede…”
BackgroundChen, R., Wang, Q., Wang, Y. Y., Wang, Y., Liu, J., Liao, Z., & Xiao, X. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1094458 · Cited by 7
Takeuchi, M., Minato, S., Kitaoka, K., Tsuboi, A., Kurata, M., Kazumi, T., & Fukuo, K. (2018) · Journal of Clinical Medicine Research · doi:10.14740/jocmr3534w · Cited by 6
Cerebrovascular pathology and metabolic syndrome
Tanashyan, M. М. (2019) · doi:10.33901/978-5-6041430-2-5-2019-1-370 · Cited by 4
Pathogenesis of Insulin Resistance
Zaman, G. S. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.92864 · Cited by 8
Shevelok, A. N. (2021) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2021-3991 · Cited by 5
Kutoh, E., Kuto, A. N., Wada, A., Kurihara, R., & Kojima, R. (2021) · Drug Research · doi:10.1055/a-1640-0226 · Cited by 5
Engin, B., Willis, S. A., Malaikah, S., Sargeant, J. A., Biddle, G. J. H., Razieh, C., Argyridou, S., Edwardson, C. L., Jelleyman, C., Stensel, D. J., et al. (2023) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000003193 · Cited by 6
Obesity as a main component of metabolic syndrome and a risk factor for comorbidity
Sharonova, L. A., Bulgakova, S. V., Dolgikh, Y. A., Kosareva, O. V., Treneva, E. V., & Kurmaev, D. P. (2024) · Экспериментальная и клиническая гастроэнтерология · doi:10.31146/1682-8658-ecg-222-2-101-110 · Cited by 4
Predicting Insulin Resistance in a Pediatric Population With Obesity
de Araujo, D. D., Morgado, C., Correia‐Pinto, J., & Antunes, H. (2023) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000003910 · Cited by 6
Suppression of Endogenous Insulin Secretion by Euglycemic Hyperinsulinemia
Karakaplan, N. D., Song, Y., LAURENTI, M. C., Vella, A. V., & Jensen, M. D. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad563 · Cited by 4
NAFLD and Insulin Resistance: A Multisystemic Disease
Gastaldelli, A. (2020) · Springer eBooks · doi:10.1007/978-3-319-95828-6_4 · Cited by 4
Self-citationZafar, U. (2020) · Springer eBooks · doi:10.1007/978-3-030-53370-0_23 · Cited by 5
Kutoh, E., Kuto, A. N., Wada, A., Kurihara, R., & Kojima, R. (2021) · International Journal of Clinical Practice · doi:10.1111/ijcp.14914 · Cited by 4
Drąg, J., Knapik-Czajka, M. E., Gawędzka, A., Gdula‐Argasińska, J., & Jaskiewicz, J. A. (2021) · Biochemistry (Moscow) · doi:10.1134/s0006297921050011 · Cited by 4
Body Mass Index - Overweight, Normal Weight, Underweight
Çakmur, H. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.105320 · Cited by 8
Antidiabetic property of fractions and pure compounds from Andrographis paniculata
Bokshi, B., Chen, H., & Ung, A. T. (2023) · Natural Product Research · doi:10.1080/14786419.2023.2294115 · Cited by 3
“However, excessive accumulation of lipids within these droplets can cause metabolic disorders (Guo et al. 2009; Gastaldelli et al. 2017).”
Youth-onset type 2 diabetes: Advances, treatments, and challenges in prevention
Sparling, D. P., & Tryggestad, J. B. (2025) · Journal of clinical lipidology · doi:10.1016/j.jacl.2025.05.020 · Cited by 3
Kutoh, E., Kuto, A. N., Okada, R., & Urushibara, N. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04573-2 · Cited by 3
“Elevated FFAs are implicated in insulin resistance, beta-cell dysfunction, cardiovascular disease, NAFLD, inflammation, and endothelial dysfunction (Gastaldelli et al. 2017, Kutoh et al., 2024).”
InfluentialMinato-Inokawa, S., Honda, M., Tsuboi-Kaji, A., Takeuchi, M., Kitaoka, K., Kurata, M., Wu, B., Kazumi, T., & Fukuo, K. (2024) · Scientific Reports · doi:10.1038/s41598-024-69181-1 · Cited by 3
“Associations of AT-IR with pancreatic β-cell function were reported. in obese adolescents, obese youth with impaired glucose tolerance, and obese middle-aged people including lean controls whose BMI averaged 25 kg/ m 218–20 .”
BackgroundThe mitochondrial pyruvate carrier regulates adipose glucose partitioning in female mice
Shannon, C. E., Bakewell, T. M., Fourcaudot, M. J., Ayala, I., Smelter, A. A., Hinostroza, E. A., Romero, G., Asmis, M., Freitas‐Lima, L. C., Wallace, M., et al. (2024) · Molecular Metabolism · doi:10.1016/j.molmet.2024.102005 · Cited by 4
“Fasting AdipoIR was calculated from free fatty acid and insulin data [34].”
MethodSerum Adropin Levels Are Elevated in Patients With Hyperthyroidism
Wang, X., Chang, X., Wang, Q., Ding, X., Wang, J., Cui, R., Wang, G., & Liu, J. (2024) · International Journal of Endocrinology · doi:10.1155/2024/7144798 · Cited by 3
“…(HOMA-IR) was calculated as the following formula: FBG (mmol/L) × FINS ( μ IU/mL)/22.5 [12], adipose tissue insulin resistance (Adipo-IR) was calculated as free fatty acid (FFA) (mmol/L) × FINS ( μ IU/mL) [13] and estimated glomerular fltration rate (eGFR) was calculated as described earlier [14].”
MethodInfluentialАбатуров, А. Е., & Нікуліна, А. О. (2025) · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · doi:10.22141/2224-0721.21.3.2025.1545 · Cited by 3
Akter, T., Song, Z., Takada, M., Hamrah, M. H., Wang, S., Endale, B. T., Paththamesthrige, S. E. P., Khine, M. T., Matsunaga, M., Ota, A., et al. (2025) · Journal of Epidemiology · doi:10.2188/jea.je20250025 · Cited by 4
“9,10,24 In the present study, we demonstrated an association between Adipo-IR and T2DM, independent of confounding factors.”
Treatment of Type 2 Diabetes in Patients with Obesity
Guzman, H., Hasan, L. Z., & Reid, T. J. (2024) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2024.10.004 · Cited by 4
Altuve, M., & Severeyn, É. (2019) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2019.05.029 · Cited by 3
Li, S., Chen, D., Xiu, M., Li, J., & Zhang, X. (2021) · Early Intervention in Psychiatry · doi:10.1111/eip.13240 · Cited by 4
“Adipocytes regulate glycolipid metabolism and increases in adipose tissue are strongly correlated with metabolic risk (Gastaldelli et al., 2017; Hotamisligil, 2017).”
BackgroundObesity is the Alleyway to Insulin Resistance and Type 2 Diabetes Mellitus
Sinha, S., & Haque, M. (2022) · Advances in Human Biology · doi:10.4103/aihb.aihb_6_22 · Cited by 4
Pokoly, B., & Somogyi, A. (2023) · Orvosi Hetilap · doi:10.1556/650.2023.32783 · Cited by 3
“[9] Gastaldelli A, Gaggini M, DeFronzo RA.”
Faraj, M. (2019) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(19)30042-2 · Cited by 6
Obesity and Diabetes Mellitus 2: Interrelated Relative Relationship
Albajy, M. A., & Mihailescu, D. F. (2023) · International Journal of Research and Review · doi:10.52403/ijrr.20230933 · Cited by 3
Sasaki, N., Ueno, Y., Ozono, R., Nakano, Y., & Higashi, Y. (2024) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2024.117547 · Cited by 3
Kang, X., Xiong, T., Yazhou, X., Chen, Y., Ruan, Y., & Guan, Q. (2025) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.70031 · Cited by 2
“32 The OGTT was conducted to evaluate the ability by the size of AUC.”
Liu, Y., Sun, J., & Zhang, X. (2025) · Endokrynologia Polska · doi:10.5603/ep.103993 · Cited by 2
Association of BMI and Cognitive Performance in the Diabetes Prevention Program Outcomes Study
Luchsinger, J. A., Pan, Q., Knowler, W. C., Munshi, M. N., Watson, K. E., Gadde, K. M., Schlögl, M., & Carmichael, O. T. (2025) · Obesity · doi:10.1002/oby.70031 · Cited by 2
“Overweight and obesity increase the risk for type 2 diabetes [3].”
Acetamiprid exerts sex-specific effects on adipose tissue of subjects with severe obesity
Zanchi, G., Tammaro, A., Monteleone, V., Varí, R., Santangelo, C., Silecchia, G., Petrucciani, N., Manella, S., Silenzi, A., Tait, S., et al. (2026) · Frontiers in Toxicology · doi:10.3389/ftox.2026.1769863 · Cited by 2
“In morbidly obese subjects, AT function is severely compromised, and insulin resistance impairs adipocyte responsiveness to insulin, reducing suppression of lipolysis (Gastaldelli et al., 2017).”
McCormick, C. D., Waters, H. N., Bezrukov, L., Taginya, R., Parikh, V. J., Onyekaba, G. I., Levine, J. A., Demidowich, A. P., Yanovski, J. A., Blank, P. S., et al. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.003751 · Cited by 3
“The San Antonio Metabolism Study highlighted that a progressive decline in pancreatic function leading to type 2 diabetes (T2D) begins with a progressive increase in circulating free fatty acids and an increase in adipose insulin resistance, identifying a potentially important role for adipose tissue in the transition…”
BackgroundHalloun, R., Galderisi, A., Caprio, S., & Weiss, R. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac700 · Cited by 2
Kistkins, S., Moser, O., Ankudovičs, V., Bļizņuks, D., Mihailovs, T., Lobanovs, S., Sourij, H., Pfeiffer, A. F. H., & Pīrāgs, V. (2024) · Endocrine Connections · doi:10.1530/ec-23-0529 · Cited by 3
“While this likely depends on several mechanisms, data from both in vitro and clinical trials suggest that impaired insulin sensitivity in white adipose tissue plays an early role in dysregulation of adipocyte metabolism and whole-body insulin resistance (8, 9).”
BackgroundDu, M., Zhang, Y., Gao, X., Xing, X., Zhang, M., Leng, M., Wang, X., Zhang, S., & Li, C. (2024) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2024.05.001 · Cited by 3
Bockarie, A. S., Derkyi‐Kwarteng, L., Obeng, J. A., Adatsi, R. K., Aniakwaa-Bonsu, E., Apprey, C., Ampofo‐Asiama, J., & Acquah, S. (2025) · PLOS Global Public Health · doi:10.1371/journal.pgph.0004506 · Cited by 2
Wen, S., Huang, X., Huang, Z., Deng, Z., Zhou, C., Chen, N., & Huang, Y. (2025) · Endokrynologia Polska · doi:10.5603/ep.104464 · Cited by 4
Kutoh, E., Kuto, A. N., Ozawa, E., Kurihara, R., & Akiyama, M. (2023) · Drug Research · doi:10.1055/a-2007-1893 · Cited by 2
“HOMA-R, HOMA-B, QUICKI, CPR-index or adipo-IR were calculated as previously described [18, 20, 21].”
MethodExosomal RNA in type 2 diabetes mellitus and other metabolic diseases
Ghoshal, K. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-14008-2.00009-7 · Cited by 3
Kutoh, E., & Kuto, A. N. (2026) · medRxiv · doi:10.64898/2026.02.16.26346332 · Cited by 2
Delgadillo‐Velazquez, J., Nambo‐Venegas, R., Patiño, N., Meraz‐Cruz, N., Razo-Azamar, M., Guevara‐Cruz, M., Fonseca, M., Montero, L. E. P., Ibarra‐González, I., Vela-Amieva, M. B., et al. (2021) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2021.06.007 · Cited by 3
Rostamizadeh, M., Elmieh, A., & Farhad, R. (2021) · Journal of Shahrekord University of Medical Sciences · doi:10.34172/jsums.2021.20 · Cited by 2
Features of molecular mechanisms of insulin resistance pathogenesis in various tissues in obesity
Kuzmenko, D. I., Klimenteva, T. K., Самойлова, Ю. Г., Denisov, N. S., & Матвеева, М. В. (2023) · Obesity and metabolism · doi:10.14341/omet12839 · Cited by 1
Second-generation antipsychotic drugs and their impact on adipose tissue
Rada, P., Ferreira, V., & Valverde, Á. M. (2024) · Anales de la Real Academia Nacional de Farmacia · doi:10.53519/analesranf.2024.90.01.02 · Cited by 2
Relationship between the main components of metabolic syndrome and oral diseases
Sharonova, L. A., Bulgakova, S. V., Burakshaev, S. A., Dolgikh, Y. A., Kosareva, O. V., Treneva, E. V., Kurmaev, D. P., & Merzlova, P. Y. (2025) · Экспериментальная и клиническая гастроэнтерология · doi:10.31146/1682-8658-ecg-228-8-131-142 · Cited by 1
Kose, T. (2025) · IntechOpen eBooks · doi:10.5772/intechopen.1011942 · Cited by 1
Foreman, N. A., Rajwade, S., Bluth, J., Skoglund, L. C., Letts, A. M., DiPietro, L., Ciarleglio, A., & Barberio, M. D. (2025) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00235.2025 · Cited by 1
Relationship between aerobic fitness and adipose tissue insulin resistance
Sharma, A., Lytle, K. A., & Jensen, M. D. (2025) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00327.2025 · Cited by 2
Wei, Y., Tian, Y., Cui, R., Wang, Y., Liu, J., & Wang, G. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70513 · Cited by 1
“Previous studies, including those involving adolescents, 4,9,10 adults, 3 and women with polycystic ovary syndrome, 31 have identified a positive relationship between adipose insulin resistance and dysglycaemia.”
Gastaldelli, A., Choi, E., Conde‐Knape, K., Göransson, O., Krook, A., Lehtonen, S. H., Roden, M., Schrauwen, P., Sparks, L. M., & Heni, M. (2026) · Diabetologia · doi:10.1007/s00125-026-06853-9 · Cited by 3
Self-citationNisa, H., & Fatihah, I. Z. (2020) · Buletin Penelitian Sistem Kesehatan · doi:10.22435/hsr.v23i4.3604 · Cited by 1
Bakour, N., Duggan, C., & Annett, S. (2025) · IntechOpen eBooks · doi:10.5772/intechopen.1008462 · Cited by 1
Quemerina, omentina-1 y miR-103p y su relación con la diabetes mellitus gestacional
García, B. C. S., Zerón, H. M., Suárez, A. C. H., & García, M. C. (2020) · Revista Colombiana de Endocrinología Diabetes & Metabolismo · doi:10.53853/encr.7.1.564 · Cited by 2
Chemokines at the Crossroad of Diabetes-Tuberculosis Synergy
Aravindhan, V., & Yuvaraj, S. (2022) · Biochemistry · doi:10.5772/intechopen.106598 · Cited by 1
Hyperinsulinemia, obesity, and diabetes mellitus
Prakash, S. S. (2022) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-022-01137-5 · Cited by 1
“Based on these observations, it can be surmised that hyperinsulinemia in obese individuals could be due to high insulin secretory capacity in the face of insulin resistance in adipose tissue to compensate but ultimately leads to β-cell failure and decreased insulin secretion, whereas in nonobese individuals it could b…”
BackgroundResultInfluentialDiabetes, Aging, and Insulin’s Reponic Features: Review
Moen, J. (2022) · Current Diabetes Reviews · doi:10.2174/1573399819666221031140713 · Cited by 1
Pathophysiology of Type 2 Diabetes: A General Overview of Glucose and Insulin Homeostasis
Ghasemi, A., & Kashfi, K. (2022) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815079814122010004 · Cited by 1
Bousahba, I., David, J., Castelli, F. A., Chollet, C., Ouzia, S., Fenaille, F., Rémond, D., Poupin, N., & Polakof, S. (2022) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-022-00940-2 · Cited by 2
Regulation of glucose transport in cardiomyocytes
Bowman, P. R. T. (2019) · Enlighten: Theses (The University of Glasgow) · doi:10.5525/gla.thesis.41002 · Cited by 2
Hendarto, A., Hafifah, C. N., Sjarif, D. R., & Alhadar, A. K. (2019) · Sari Pediatri · doi:10.14238/sp20.4.2018.237-41
Investigations of the Mechanisms of Diabetes Remission: A Focus on Adaptive Thermogenesis
Corley, B. (2019) · Otago University Research Archive (University of Otago) · Cited by 2
Metadata
- Authors
- Gastaldelli, A., Gaggini, M., & DeFronzo, R. A.
- Affiliations
- The University of Texas at San Antonio Health Science Center (US)
- Istituto di Fisiologia Clinica (IT)
- Corresponding author
- Gastaldelli, Amalia
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2017-01-04
- Volume
- 66
- Issue
- 4
- Pages
- 815-822
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2571158149
- Cited by
- 344
- References
- 41
- Citations by year
- 2026: 20 · 2025: 35 · 2024: 35 · 2023: 44 · 2022: 46 · 2021: 62 · 2020: 43 · 2019: 28 · 2018: 25 · 2017: 6
- FWCI
- 21.77
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes (publishedVersion)
- PubMed (publishedVersion)
- Funders
- EU Horizon 2020 project EpoS (634413)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Keywords
- adipose tissue insulin resistance, type 2 diabetes, impaired glucose tolerance, beta-cell function, free fatty acids, insulin resistance, obesity, glucose tolerance, Matsuda index
- MeSH terms
- Adipose Tissue, Adult, Blood Glucose, Diabetes Mellitus, Type 2, Fatty Acids, Nonesterified, Female, Glucose Tolerance Test, Humans, Insulin, Insulin Resistance, Male, Middle Aged, Obesity, Glucose Clamp Technique, Case-Control Studies, Glucose Intolerance
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.